These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 20160723

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.
    Kinoshita T, Nohata N, Fuse M, Hanazawa T, Kikkawa N, Fujimura L, Watanabe-Takano H, Yamada Y, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N.
    Biochem Biophys Res Commun; 2012 Feb 10; 418(2):378-83. PubMed ID: 22266319
    [Abstract] [Full Text] [Related]

  • 24. miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.
    Liu Y, Hong W, Zhou C, Jiang Z, Wang G, Wei G, Li X.
    Oncol Rep; 2017 May 10; 37(5):2593-2602. PubMed ID: 28393215
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer.
    Zhou Y, Wu D, Tao J, Qu P, Zhou Z, Hou J.
    Scand J Urol; 2013 Oct 10; 47(5):423-32. PubMed ID: 23206218
    [Abstract] [Full Text] [Related]

  • 26. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.
    Yonemori M, Seki N, Yoshino H, Matsushita R, Miyamoto K, Nakagawa M, Enokida H.
    Cancer Sci; 2016 Sep 10; 107(9):1233-42. PubMed ID: 27355528
    [Abstract] [Full Text] [Related]

  • 27. Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
    Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Nohata N, Yamasaki T, Gotanda T, Tachiwada T, Seki N, Nakagawa M.
    Int J Oncol; 2012 Apr 10; 40(4):951-9. PubMed ID: 22179486
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.
    Chiyomaru T, Tatarano S, Kawakami K, Enokida H, Yoshino H, Nohata N, Fuse M, Seki N, Nakagawa M.
    Prostate; 2011 Oct 01; 71(14):1559-67. PubMed ID: 21360565
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer.
    Li Y, Gao Y, Xu Y, Ma H, Yang M.
    Growth Factors; 2015 Oct 01; 33(4):267-74. PubMed ID: 26359764
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P, Speeckaert R, De Wever O, Chevolet I, Brochez L, Lambert J, Van Gele M.
    Int J Oncol; 2013 Apr 01; 42(4):1443-51. PubMed ID: 23404256
    [Abstract] [Full Text] [Related]

  • 40. Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion.
    Chen JJ, Cai WY, Liu XW, Luo QC, Chen G, Huang WF, Li N, Cai JC.
    PLoS One; 2015 Apr 01; 10(5):e0126890. PubMed ID: 26010149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.